Medical/Pharmaceuticals
Transcenta Received Approvals from China CDE and South Korea MFDS to Initiate TranStar 301 Global Phase III Pivotal Trial of Osemitamab (TST001)
SUZHOU, China, July 7, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that it has received ...
2023-07-07 15:52
4437
MGI's DNBSEQ-T7* Receives Approval for Clinical Use in South Korea
SEOUL, South Korea, July 6, 2023 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, announced its ultra-high-throughput genetic sequencer DNBSEQ-T7 received the medical device registration certificate from the Korea Ministry of...
2023-07-06 09:00
4166
Brii Biosciences Broadens its Leadership in Hepatitis B with a Portfolio Now Addressing Disease's Burdens from Prevention to Cure
Extension of BRII-179 license from VBI Vaccines to global rights bolsters Brii Bio's position to achieve best-in-class HBV functional cure in broad patient populations Company also acquires exclusive rights to PreHevbri®, a clinically differentiated, 3-antigen prophylactic vaccine, from VBI inGr...
2023-07-06 07:25
5008
Brii Biosciences Provides Latest Clinical Development and Corporate Updates
Company extends BRII-179 license to global rights and introduces preventive vaccine, PreHevbri® in Greater China and Asia Pacific markets New data from BRII-835 + PEG-IFN-α study have demonstrated that robust anti-HBs antibody responses at the end of treatment are associated with sustained HBsA...
2023-07-06 07:19
5579
Sirnaomics Establishes a Strategic Partnership with EDIRNA Inc., an RNA-Editing Therapeutic Company
HONG KONG and GERMANTOWN, Md. and SUZHOU BIOBAY, China, July 5, 2023 /PRNewswire/ --Sirnaomics Ltd. (the "Company", stock code: 2257, together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced...
2023-07-05 23:07
4015
apoQlar secures funding led by YZR Capital, revolutionizes surgical care through partnerships
HAMBURG, Germany, July 5, 2023 /PRNewswire/ -- apoQlar, a pioneering healthtech company, has successfully secured a funding round led by venture capital firm YZR Capital, specializing in health tech investments. This significant investment validates the potential of apoQlar's advanced augmented r...
2023-07-05 13:00
3570
GILEAD SCIENCES AND IAS - THE INTERNATIONAL AIDS SOCIETY - HONOUR HEALTHCARE PROVIDERS GLOBALLY WHO CHAMPION STIGMA-FREE HIV SERVICES
— The 2023 Me and My Healthcare Provider (MMHCP) campaign, supported by Gilead for the second year running, honours frontline workers providing exemplary inclusive, stigma-free HIV services in Brazil,Hong Kong, Mexico and Taiwan — — The IAS also debuts a novel, stigma-free services "cookbook" for...
2023-07-05 11:00
3239
VentureBlick Secures US$2.6M for First Two Startups, Unveils Super Incubator Model for Medtech Innovation
SINGAPORE, July 5, 2023 /PRNewswire/ -- VentureBlick, a global venture platform for healthcare innovation, announces the successful closure of its first two deals, securing a total ofUS$2.6 million for two startups despite a challenging funding environment. This achievement is a testament of Vent...
2023-07-05 10:00
5237
Chula Researchers Find "Extreme Stress and Depression" Chemicals in Sweat and Successfully Test Firefighters' Mental Health for the First Time!
BANGKOK, July 4, 2023 /PRNewswire/ -- Further to the success of the COVID-19 sweat test, Assistant Professor Dr.Chadin Kulsing, Department of Chemistry, Faculty of Science, in collaboration with Dr. Patthrarawalai Sirinara, MD, MPH Department of Preventive and Social Medicine, Faculty of Medicin...
2023-07-04 16:59
4741
PharmaLedger Reaches 30+ Members Demonstrating the Ecosystem Trend in Digital Health
BASEL, Switzerland, July 4, 2023 /PRNewswire/ -- The PharmaLedger Association,
a pioneering nonprofit organization dedicated to fostering a secure and reliable
Digital Trust Ecosystem
2023-07-04 10:30
3906
AFTER FIVE YEARS OF SUCCESSFUL EXPERIENCE INTERNATIONALLY, BIOCON BIOLOGICS' HULIO® BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES
BRIDGEWATER, N.J. and BENGALURU, India, July 3, 2023 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, today announced that HULIO® (adalimumab-fkjp) injection, a biosimilar to Humira® (adalimumab), is now available to patients inthe United States after five years of experien...
2023-07-04 01:22
3088
Lumos Receives US FDA Clearance for FebriDx®
MELBOURNE, Australia, July 3, 2023 /PRNewswire/ -- Lumos Diagnostics (ASX: LDX), ("Lumos" or the "Company") a leader in rapid, point-of-care (POC) diagnostic technologies, is pleased to announce that it has received clearance from the US Food and Drug Administration (FDA) to market its FebriDx® r...
2023-07-03 21:50
3680
Henlius Forecasts Profit in 1H 2023
Spurring a Seamless R&D, Manufacturing, and Commercialisation Positive Cycle SHANGHAI, July 3, 2023 /PRNewswire/ -- Henlius (2696.HK) released a positive profit forecast. Based on the preliminary assessment of the unaudited comprehensive management accounts for the six months endedJune 30, 2023, ...
2023-07-03 18:59
6051
Singapore Hosts the 25th World Congress of Dermatology - The First in Southeast Asia, Drawing Over 11,000 Delegates to Discuss New Developments in Skin Research and Treatments
Themed 'Dermatology Beyond Borders', WCD2023 is one of the largest international medical conventions in the region, and is set to gather over 11,000 local and foreign delegates, including clinicians, scientists, other health-care professionals and industry partners across 130 countries to unveil ...
2023-07-03 18:29
4159
SHL Medical acquires 100% of the shares in Swiss company LCA Automation
SHL Medical announces the acquisition of LCA Automation AG, a Swiss innovative automation solutions provider. The acquisition is SHL Medical's response to the growing market demand for drug delivery solutions and will support its manufacturing operations globally, especially the upcomingSwiss man...
2023-07-03 17:00
4552
Alma, a Sisram Medical company, is establishing a direct operation in China after completing the acquisition of PhotonMed
HONG KONG, July 3, 2023 /PRNewswire/ -- Alma, the world leader and innovator in providing energy-based medical and aesthetic solutions and a wholly-owned company by Sisram Medical (1696.HK), announced today that it has completed the acquisition of PhotonMed International Ltd ("PhotonMed"), the le...
2023-07-03 15:48
6583
Fair Play Menarini International Awards, the 2023 edition starts with the talk show "The Champions tell their Stories" in Piazza della Signoria, Florence
FLORENCE, Italy, July 3, 2023 /PRNewswire/ -- The countdown has begun to the XXVII edition of the Fair Play Menarini International Awards. Tomorrow, Monday, July 3rd, the 2023 edition of the event, dedicated to the sporting values of ethics, fair play and respect, will officially begin in the cit...
2023-07-03 09:31
3884
Innovent and IASO Bio Announce the NMPA Approval of FUCASO®, the First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed or Refractory Multiple Myeloma
ROCKVILLE, Md. and SUZHOU, China, July 3, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...
2023-07-03 08:00
6473
Lifera and CENTOGENE, Enter Strategic Collaboration - Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing
* Joint Venture (JV) combines CENTOGENE's global leadership in multiomics with local insight of Lifera, a biopharmaceutical company wholly owned by the Public Investment Fund (PIF) based inRiyadh. * JV focuses on providing state-of-the-art multiomic testing services to patients, health system...
2023-07-02 14:00
4732
Clinical Trial Data of Novel Metabolic Mechanism in Migraine: CER-0001, a Ketogenic Investigational Agent
* A poster showcasing data from the RELIEF study of CER-0001 (tricaprilin), being investigated for the preventive treatment of migraine, was presented at the 65th Annual Society Meeting of the American Headache Society * Data from the pilot study, showed a positive efficacy signal and supports...
2023-07-01 00:52
5376
Week's Top Stories
Most Reposted
Agoda and Emerging Travel Group Enter Strategic Partnership
[Picked up by 293 media titles]
2026-10-15 16:00Food & Hospitality Asia 2027 Redefining Excellence: The Premier Platform for Food & Beverage and Hospitality Innovation
[Picked up by 282 media titles]
2026-10-15 10:00SALMON SECURES $140 MILLION (PHP 8.8 BILLION) TO DOUBLE DOWN ON THE GROWTH OPPORTUNITY IN THE PHILIPPINES
[Picked up by 282 media titles]
2026-10-19 13:18
Leading Asian DMC Discova to Attend ITB Asia 2026
[Picked up by 280 media titles]
2026-10-15 12:59
DayOne Upsizes Malaysia Financing to US$7.2 Billion; Total Billings Surpass 1GW and Bookings Reach 2.3GW
[Picked up by 270 media titles]
2026-10-14 18:01Most Read
Sonilo Raises $11M to Build the AI-Native Audio Stack for Video
2026-10-15 00:00
26664
Agoda and Emerging Travel Group Enter Strategic Partnership
2026-10-15 16:00
16049